House Democrats unveil new $2.2 trillion coronavirus relief proposal...
Trump Announces Plan to Ship 150 Million Rapid Coronavirus Tests...
Operation Warp Speed: vast military involvement
As insurers move this week to stop waiving telehealth copays, patients may have to pay more for virtual care...
Molina To Buy Affinity Health Plan For $380 Million In Medicaid Deal...
UHS hit with massive cyber attack as hospitals reportedly divert surgeries, ambulances...
Court ruling may change M&A disclosure between health systems, unions...
Harvard Pilgrim commits $1M+ to expand telehealth at 120 independent clinics...
Current telehealth reimbursement still a “band-aid,” says Amwell’s CEO...
What IPO and Walmart deal mean for fast-growing Oak Street Health...
Some Workers Face Looming Cutoffs in Health Insurance...
Blues Reach Tentative $2.7B Antitrust Settlement...
Rite Aid: Store And PBM Rebrand ‘Well Underway’...
CMS: 2021 Medicare Advantage premiums to hit lowest point since 2007...
UnitedHealth in Talks to Buy Pharmacy Startup DivvyDose...
Aledade's ACOs have saved more than $400M over last 5 years...
Patient sentiment improving on elective procedures despite ongoing pandemic, survey suggests...
Amazon expands virtual health care for employees throughout Washington state...
Walmart Is Going To Try Drone Deliveries Of Quest Diagnostics’ At-Home Coronavirus Tests...
Daniel Hilferty retiring as chief executive officer of Independence Blue Cross...
Optum: How payers can prepare now for wave of CAR-T therapies...
Bright Health raises $500M, plans expansion into employer-based insurance...
Mayo’s Chief Digital Officer: The hospital of the future isn’t just about technology...
You Might Like
CORONAVIRUS
Gottlieb fears U.S. headed for ‘most dangerous season’ for coronavirus infections...
‘Helpless’ doctors at start of coronavirus pandemic now have more treatments to save lives...
DoD tests wearables’ ability to detect Covid-19 before symptoms appear...
Fauci Sees Covid-19 Vaccines For Different Patients With Five In Final-Stage U.S. Trials...
Fewer than 10% of Americans show signs of past coronavirus infection, study finds...
Why so many people are hopeful about an mRNA coronavirus vaccine...
Cuomo to form review council for COVID-19 vaccines, says he's wary of approval process politicization...
Trump’s coronavirus vaccine czar says he’s had ‘enough’ of Democratic calls for his firing over pharma stock holdings...
Democrats Prepare New Coronavirus Aid Proposal...
CMS raises alarm as vaccinations, screenings decline in Medicaid and CHIP due to COVID-19...
F.D.A. to Release Stricter Guidelines for Emergency Vaccine Authorization...
Verma: CMS will mull which COVID-19 flexibilities may stick around post-pandemic...
Three Million Lost Employer Health Coverage In Pandemic’s Wrath...
FOLLOW HEALTHCARE REPORT ON TWITTER...
JOIN HEALTHCARE REPORT'S DAILY EMAIL LIST HERE...
Drug industry CEOs will testify this week about some of pharma’s most controversial medicines...
REUTERS: Google set to win EU okay for Fitbit deal with fresh concessions...
Opioid Victims Seek Chance to Take Purdue’s Owners to Court...
Pandemic drives hike in opioid deaths...
Pfizer urged to hold off on coronavirus vaccine until late November...
Apple Watch's abnormal pulse feature driving many unnecessary healthcare visits, Mayo Clinic researchers say...
Why so many people are hopeful about an mRNA coronavirus vaccine...
Merck, advancing single-dose and oral coronavirus vaccines, could still make Warp Speed...
J&J signs manufacturing deal with GRAM for potential COVID-19 vaccine...
FDA will allow states to import drugs from Canada...
Novavax’s Coronavirus Vaccine Enters Late-Stage Trials...
Cognoa targets De Novo authorization for its autism diagnostic after reporting strong pivotal study results...
China's Sinovac eyes coronavirus vaccine distribution in South America...
Race for Vaccine: slow starters could still win out...
AZ waits for FDA go-ahead to resume U.S. trial...
Pfizer partner BioNTech sees no role for its vaccine in UK challenge trial...
GoodRx closes up 53% in market debut...
Novartis faces delay after FDA asks for another Zolgensma study...
BMS, bluebird get sped-up review for multiple myeloma CAR-T cell therapy...
Medtronic gets FDA breakthrough tag for device to prevent infections...
Labs, diagnostics, dialysis sectors predicted to recover by year-end, but S&P cautious on device outlook...
Coronavirus vaccine makers see EU shield against side-effect claims...
Permira buys German specialty pharma group Neuraxpharm...
Merck matches Roche in search for next cancer immunotherapy...
Pharma companies don’t want unicorn digital therapeutic partnerships...
Illumina to pay $8 billion for Jeff Bezos-backed cancer testing firm Grail...
AstraZeneca, Under Fire for Vaccine Safety, Releases Trial Blueprints...
Trial still on hold in US...
EU agency recommends AstraZeneca-Merck drug Lynparza for two cancers...
Pfizer vaccine trial bets on early win against coronavirus, documents show...
Moderna to seek limited emergency use of COVID-19 vaccine if data shows high efficacy...
Lilly partners with Amgen for manufacturing potential COVID-19 drugs...
Combo study of Gilead antiviral, Lilly anti-inflammatory drug positive in Covid-19, but raises pricing jitters...
Moderna expects to know if its coronavirus vaccine works by November, CEO says...
Moderna Shares the Blueprint for Its Coronavirus Vaccine Trial...
Russia to sell COVID-19 vaccine to India's Dr. Reddy's Laboratories...
You Might Like
